| # | Drug | Count |
|---|---|---|
| 0 | RISPERIDONE | 1559 |
| 1 | PALIPERIDONE PALMITATE | 954 |
| 2 | OLANZAPINE | 468 |
| 3 | PALIPERIDONE | 403 |
| 4 | QUETIAPINE | 384 |
| 5 | ARIPIPRAZOLE | 381 |
| 6 | CLOZAPINE | 231 |
| 7 | OLANZAPINE PAMOATE | 180 |
| 8 | ARIPIPRAZOLE ORAL | 166 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 166 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UREA 39% CREAM | 1 | 0.0667 |
| 1 | ZIPRASIDONE | 110 | 0.0305 |
| 2 | PALIPERIDONE PALMITATE | 954 | 0.0292 |
| 3 | FLUPHENAZINE DECANOATE | 10 | 0.0230 |
| 4 | BROMOCRIPTINE MESYLATE | 14 | 0.0217 |
| 5 | PIMOZIDE | 10 | 0.0207 |
| 6 | RISPERIDONE | 1559 | 0.0207 |
| 7 | AMISULPRIDE | 103 | 0.0168 |
| 8 | CABERGOLINE | 76 | 0.0154 |
| 9 | TIAGABINE HYDROCHLORIDE | 1 | 0.0119 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 2467 |
| 1 | Benzodiazepine [EPC] | 352 |
| 2 | Mood Stabilizer [EPC] | 210 |
| 3 | Anti-epileptic Agent [EPC] | 204 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 119 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 104 |
| 6 | Corticosteroid [EPC] | 89 |
| 7 | Typical Antipsychotic [EPC] | 83 |
| 8 | Ergot Derivative [EPC] | 76 |
| 9 | Proton Pump Inhibitor [EPC] | 74 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 76 | 0.0154 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 104 | 0.0133 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 10 | 0.0081 |
| 3 | Atypical Antipsychotic [EPC] | 2467 | 0.0055 |
| 4 | Typical Antipsychotic [EPC] | 83 | 0.0033 |
| 5 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 6 | Provitamin D2 Compound [EPC] | 45 | 0.0015 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 72 | 0.0013 |
| 8 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 9 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |